Abstract
Proton magnetic resonance spectroscopy is used to measure several metabolites in cortical gray and white matter in patients with Huntington's disease. The preliminary results show that CAG-repeat length correlates with white-matter N-acetylaspartate concentrations, and disease severity correlates with several metabolites. © 2014 by the American Psychiatric Association.
Cite
CITATION STYLE
Yager, J. R., Gasparovic, C., Magnotta, V. A., Adams, W., Fiedorowicz, J., Paulsen, J., … Beglinger, L. J. (2014). Preliminary study of the association of white-matter metabolite concentrations with disease severity in patients with Huntington’s disease. Journal of Neuropsychiatry and Clinical Neurosciences, 26(1), 101–104. https://doi.org/10.1176/appi.neuropsych.13020040
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
